Clinical and Radiologic Signs of Relapsed Ovarian Germ Cell Tumor: Tissue Is the Issue

por Homs, M. Y. V., Schreuder, H. W. R., Jonges, G. N., Witteveen, P. O.
Publicado 2013

Patient-reported outcome measures in a pharmacokinetic study with sunitinib, a prospective cohort study

por Koldenhof, J. J., Lankheet, N. A. G., Steeghs, N., Teunissen, S. C. C. M., Witteveen, P. O.
Publicado 2018

Prospective practice survey of management of cetuximab-related skin reactions

por Lugtenberg, R. T., Boers-Doets, C. B., Witteveen, P. O., van Herpen, C. M. L., Wymenga, A. N. M., de Groot, J. W. B., Hoeben, A., del Grande, C., van Doorn, B., Koldenhof, J. J., Driessen, C. M. L., Gelderblom, H.
Publicado 2020

Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours

por Kerklaan, B Milojkovic, Lolkema, M P J, Devriese, L A, Voest, E E, Nol-Boekel, A, Mergui-Roelvink, M, Langenberg, M, Mykulowycz, K, Stoebenau, J, Lane, S, Legenne, P, Wissel, P, Smith, D A, Giantonio, B J, Schellens, J H M, Witteveen, P O
Publicado 2015